The MTPConnect Podcast

Radiopharmaceuticals are precision nuclear medicines used for medical imaging and treatment that allow doctors to diagnose and deliver targeted therapies for diseases such as cancer. A new discussion paper from MTPConnect, ‘From Mines to Medicines. Australia’s Radiopharmaceuticals Future’ reveals how Australia is ready to play a leading role in the rise of the global radiopha

Perth- based biotech Argenica Therapeutics is developing therapies to treat stroke and other neurological conditions. A new neuroprotective peptide treatment is now being tested for ischaemic stroke patients presenting to emergency departments at 10 hospitals around Australia and is expected to improve patient outcomes by protecting the brain tissue from dying until blood flow can

Innovators have told us that funding is important but difficult to navigate. The Australian Government is committed to investing billions of dollars into medical research and industry growth, cultivating a culture of translation and improving health for all Australians. So MTPConnect’s Adelaide Intermediary Program kicked off its first SA Insights event in 2024 by bringing the Co

MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program held its first annual Symposium in Sydney recently, bringing together all 11 companies from around Australia who are recipients of CTCM funding to develop new medical devices to improve health and wellbeing.In this episode, host Caroline Duell meets some of these Australian trailblazers - Eudaemon Tech

The GSK Australia Graduate Researcher Program (GRP) is a 12-month work placement program for PhD graduates supported by MTPConnect's Researcher Exchange and Development within Industry (REDI) initiative showcasing opportunities in the pharmaceutical industry by providing hands-on experience for postdoctoral biomedical/science researchers.Since 2021, the GRP program has been op

The GSK Australia Graduate Researcher Program (GRP) is a 12-month work placement program for PhD graduates supported by MTPConnect's Researcher Exchange and Development within Industry (REDI) initiative showcasing opportunities in the pharmaceutical industry by providing hands-on experience for postdoctoral biomedical/science researchers.Since 2021, the GRP program has been op

As thousands in the medical technology sector headed to Anaheim, California for The MedTech 2023 Conference, MTPConnect was making sure that the 20 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections. In this podcast special from Los Angeles, our CEO Stuart Dignam wa

Dubbed the superbug pandemic, antimicrobial resistance (AMR) has been recognised by the World Health Organization as one of the top 10 public health threats facing humanity. Effective antibiotics underpin modern medicine and yet, it takes just two to three years for new antimicrobial medicines to become ineffective against superbugs. Worryingly, the innovation pipeline for new anti

Many well-known Australian medical innovations have been developed by visionary clinicians – doctors, nurses and allied health professionals – including the cochlear implant and spray on skin. In this special series we continue to explore how medical entrepreneurship can transform healthcare and meet Associate Professor Fiona Brownfoot, a specialist obstetrician and a clinician

Many well-known Australian medical innovations have been developed by visionary clinicians – doctors, nurses and allied health professionals – including the cochlear implant and spray on skin. In part 1 of this double episode, we explore medical entrepreneurship in Australia with Dr Brandon Carp, a Melbourne-based doctor who changed up his medical career to pursue his entrepren